Seen an ad with an AI influencer or actor? It may be against the law.
THE SO WHAT
New York’s synthetic performer disclosure law colliding with FTC authority questions means AI-generated faces in ads are now a compliance surface, not just a creative choice. If you’re using AI talent in campaigns, assume multi-jurisdictional disclosure rules are coming and standardize provenance and labeling now rather than retrofitting later.
READ THE SOURCE
MORE FROM THE WIRE
Applied AINvidia strikes $12.9bn deal for Hugging Face, reports say
If Nvidia absorbs Hugging Face, the open-source AI commons becomes vertically integrated into the leading hardware vendor—model distribution, community, and infra would sit on the same balance sheet. For operators, that would tilt the build-vs-buy calculus toward Nvidia’s ecosystem and make true vendor-neutral model strategy harder to maintain.
Applied AIOpenAI to start showing ads on ChatGPT’s free and Go tiers in India
ChatGPT’s free and Go tiers in India—over 100M weekly users—are becoming an ad surface, not just a product. If you rely on these tiers for workflows or distribution, expect UX changes, new policy constraints, and pressure to move serious usage to paid, ad-free channels.
Applied AIHuman Reviewers Need Support to Keep AI Models From Going Rogue
If human reviewers are the last line between powerful models and bad outcomes, they need real authority, tooling, and air cover—not just a checklist. Executives deploying advanced AI should treat oversight as an organizational design problem, not a staffing line item.
Applied AIHuawei plans more AI pharma partnerships, mainly with Chinese drugmakers
Huawei bundling compound screening tools with Ascend and Kunpeng into AI-pharma partnerships is another step toward a vertically integrated Chinese drug discovery stack. Global pharma and infra vendors should assume a parallel ecosystem is forming—data, models, and hardware—that may be harder to interoperate with later.